Skip to main content
  • More from ADA
    • Diabetes Care
    • Clinical Diabetes
    • Diabetes Spectrum
    • ADA Standards of Medical Care in Diabetes
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care
  • Subscribe
  • Log in
  • My Cart
  • Follow ada on Twitter
  • RSS
  • Visit ada on Facebook
Diabetes

Advanced Search

Main menu

  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • ADA Scientific Sessions Abstracts
  • Browse
    • By Topic
    • Issue Archive
    • Saved Searches
    • ADA Scientific Sessions Abstracts
    • Diabetes COVID-19 Article Collection
    • Diabetes Symposium 2020
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
    • Guidance for Reviewers
  • Reprints/Reuse
  • Advertising
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Submit Cover Art
    • ADA Journal Policies
    • Instructions for Authors
    • ADA Peer Review
  • More from ADA
    • Diabetes Care
    • Clinical Diabetes
    • Diabetes Spectrum
    • ADA Standards of Medical Care in Diabetes
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care

User menu

  • Subscribe
  • Log in
  • My Cart

Search

  • Advanced search
Diabetes
  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • ADA Scientific Sessions Abstracts
  • Browse
    • By Topic
    • Issue Archive
    • Saved Searches
    • ADA Scientific Sessions Abstracts
    • Diabetes COVID-19 Article Collection
    • Diabetes Symposium 2020
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
    • Guidance for Reviewers
  • Reprints/Reuse
  • Advertising
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Submit Cover Art
    • ADA Journal Policies
    • Instructions for Authors
    • ADA Peer Review
Islet Studies

High Glucose Causes Apoptosis in Cultured Human Pancreatic Islets of Langerhans

A Potential Role for Regulation of Specific Bcl Family Genes Toward an Apoptotic Cell Death Program

  1. Massimo Federici1,
  2. Marta Hribal1,
  3. Lucia Perego2,10,
  4. Marco Ranalli3,
  5. Zaira Caradonna2,
  6. Carla Perego4,
  7. Luciana Usellini5,
  8. Rita Nano6,
  9. Paolo Bonini1,
  10. Federico Bertuzzi6,
  11. Lionel N.J.L. Marlier12,
  12. Alberto M. Davalli7,
  13. Orazio Carandente8,
  14. Antonio E. Pontiroli2,10,
  15. Gerry Melino3,
  16. Piero Marchetti9,
  17. Renato Lauro1,
  18. Giorgio Sesti11 and
  19. Franco Folli2
  1. 1Department of Internal Medicine, University of Rome “Tor Vergata,” Rome
  2. 2Unit for Metabolic Diseases, Scientific Institute for Research and Cure (IRCCS), Hospital San Raffaele, Milan
  3. 3IDI-IRCCS Biochemistry Lab c/o the Department of Experimental Medicine, University of Rome “Tor Vergata,” Rome
  4. 4National Research Center (CNR), Centro per lo Studio della Farmacologia Cellulare e Molecolare, Milano
  5. 5Department of Surgical Pathology, Università dell’Insubria, Varese; Departments of
  6. 6Surgery
  7. 7Medicine, and
  8. 8Cardiology, IRCCS HS Raffaele, Milan
  9. 9Department of Endocrinology and Metabolism, University of Pisa, Pisa
  10. 10Department of Internal Medicine, University of Milan, Milan
  11. 11Department of Clinical and Experimental Medicine, University of Catanzaro, Catanzaro
  12. 12Institute of Neurobiology and Molecular Medicine, CNR, Rome, Italy
Diabetes 2001 Jun; 50(6): 1290-1301. https://doi.org/10.2337/diabetes.50.6.1290
PreviousNext
  • Article
  • Figures & Tables
  • Info & Metrics
  • PDF
Loading

Article Figures & Tables

Figures

  • Tables
  • FIG. 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIG. 1.

    A-E: Validation of RT-PCR for amplification of Bcl and housekeeping genes in human islets cultured in high glucose versus normal glucose. Cycle titration curves of RT-PCR amplification for housekeeping genes, cyclophyllin (A) and α-tubulin (B), and Bcl family genes, Bcl-xl (C), Bad (D), and Bid (E), in human islets treated under normal glucose (NG5, •) or high glucose (HG5, ○) conditions. Means ± SD of two separate experiments of relative expression of the genes are shown in graph.

  • FIG. 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIG. 2.

    A-H: Assessment of apoptosis in human islets cultured in high glucose versus normal glucose. A: Human islets (400 per experimental point) were cultured under HG5, NG5 (7 preparations), and NG5+MAN5 (3 preparations) conditions. At the end of treatment, the islets were dissociated and the cells were fixed and analyzed for apoptosis after propidium iodide staining, by flow cytometry. The extent of apoptosis was increased in HG5 islets compared with NG5 islets and NG5+MAN5 (**P < 0.01 and *P < 0.05 by ANOVA). The data represent the means ± SD from four independent preparations (NG5 and HG5) and three independent preparations (NG5, HG5, and NG5+MAN5), respectively, analyzed in duplicate; each experimental point was evaluated twice by flow cytometry counting 10,000 events. B: Fluorescent DNA fragmentation assays and immunostaining for insulin were performed in dissociated human islets cultured under HG5 and NG5 conditions to analyze apoptosis (TUNEL) and relative abundance of β-cells and non–β-cells. Fluorescence microscopic fields were photographed individually and merged to detect β-cell death under NG5 and HG5 conditions. The extent of apoptosis was increased in HG5 islets compared with NG5 islets (*P < 0.05, by ANOVA). The data represent the means ± SD from four independent preparations. The number of apoptotic cells was evaluated by counting the number of TUNEL-positive cells in each field (100 cells for field) by two independent researchers in a blinded manner on a total of 103 dissociated cells from each preparation. In C-H, dissociated β-cells from human islets (insulin staining, red), treated as described above, are shown. Fluorescent DNA fragmentation was detected by TUNEL (green). Representative fields for NG5 and HG5 are C-E and F-H, respectively.

  • FIG. 3.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIG. 3.

    A-D: Immunoelectron microscopy of human islets cultured in high glucose versus normal glucose. Immunoelectron microscopic analysis of islets was performed as described in research design and methods. A: Human pancreatic β-cells cultured under NG5 conditions show densely granulated insulin-containing cells. B: Intense gold-immunolabeling of insulin-containing granules. C: β-cells appeared completely degranulated after exposure to HG5 conditions. D: β-cells cultured under HG5 conditions showed features of a proapoptotic stage.

  • FIG. 4.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIG. 4.

    A-E: Bcl family gene regulation in human islets cultured in high versus normal glucose. Expression of Bcl-2, Bcl-xl, Bad, Bid, and Bik mRNA was detected by RT-PCR and quantified by FluorImager analysis of ethidium bromide signal. In each experiment, band densities were normalized against cyclophyllin, and the results are expressed as mRNA level to NG1 control islets (NG1 = 100%). A: Bcl-2. B: Bcl-xl (HG5 vs. NG5, **P < 0.01). C: Bad (HG5 vs. NG5, **P < 0.01). D: Bid (HG5 vs. NG5, ***P < 0.001). E: Bik (HG5 vs. NG5, **P < 0.01). One representative gel is also shown. Islets from six donors were analyzed. Means ± SD of relative expression of the genes are shown in bar graph. Statistical analysis was performed by ANOVA.

  • FIG. 5.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIG. 5.

    A-H: Immunofluorescence analysis of Bcl family genes in normal human pancreas. Insulin-positive signal was used as a marker of islets of Langerhans. Sections were stained with the following antibodies: anti-Bid (A); anti-Bad (C); anti-Bik (E); and anti–Bcl-xl (G). The same sections were double stained with anti-insulin antibodies to identify islets of Langerhans (B, D, F, and H). Note the robust expression of Bid and Bad in islets, and expression of Bik and Bcl-xl in both endocrine and exocrine cells (original magnification 150×).

  • FIG. 6.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIG. 6.

    A-N: Immunofluorescence analysis of Bcl family genes in human islets of Langerhans. Human pancreatic sections were stained with the following antibodies: anti-Bid (A); anti-Bad (E); anti-Bik (G); anti–Bcl-xl (L); anti-insulin (B and D); antiglucagon (H); and antichromogranin (M). Note the expression of proteins in the cytoplasmic compartment of cells. Merged confocal sections showed almost complete colocalization of Bid and Bad with insulin (C and F, respectively), a partial colocalization of Bik with glucagon (I), and a partial colocalization of Bcl-xl with chromogranin (N) (original magnification 330×).

Tables

  • Figures
  • TABLE 1

    Insulin and proinsulin secretion and content of human islets of Langerhans cultured in NG5, HG5, and NG5+MAN5

    NG5HG5NG5+MAN5
    Chronic insulin release (nmol/l/mg/day)925.50 ± 129.10*2,843.00 ± 337.021,060.40 ± 186.50*
    Basal insulin secretion (nmol/l/mg/min)0.0574 ± 0.0070.043 ± 0.0070.064 ± 0.004
    Stimulated insulin release (nmol/l/mg/min)0.49 ± 0.035†0.129 ± 0.0350.68 ± 0.07†
    Insulin content (nmol/l/mg/min)101 ± 25‡23.9 ± 5.7‡284.1 ± 16.7‡
    Chronic proinsulin release (nmol/l/mg/day)0.26 ± 0.14§1.83 ± 0.1310.39 ± 0.12§
    Proinsulin content (nmol/l/mg/min)15.10 ± 0.02∥6.60 ± 0.01∥39.05 ± 0.03∥
    • Data are means ± SD of three separate experiments in three different human islet preparations and analyzed by ANOVA.

    • * NG5 vs. HG5 and NG5+MAN5 vs. HG5 (P < 0.01);

    • † NG5 vs. HG5 and NG5+MAN5 vs. HG5 (P < 0.01);

    • ‡ NG5 vs. HG5, NG5+MAN5 vs. HG5, NG5 vs. NG5+MAN5 (P < 0.01);

    • § NG5 vs. HG5 and NG5+MAN5 vs. HG5 (P < 0.001);

    • ∥ NG5 vs. HG5, NG5+MAN5 vs. HG5, NG5 vs. NG5+MAN5 (P < 0.001).

PreviousNext
Back to top

In this Issue

June 2001, 50(6)
  • Table of Contents
  • Index by Author
Sign up to receive current issue alerts
View Selected Citations (0)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about Diabetes.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
High Glucose Causes Apoptosis in Cultured Human Pancreatic Islets of Langerhans
(Your Name) has forwarded a page to you from Diabetes
(Your Name) thought you would like to see this page from the Diabetes web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
High Glucose Causes Apoptosis in Cultured Human Pancreatic Islets of Langerhans
Massimo Federici, Marta Hribal, Lucia Perego, Marco Ranalli, Zaira Caradonna, Carla Perego, Luciana Usellini, Rita Nano, Paolo Bonini, Federico Bertuzzi, Lionel N.J.L. Marlier, Alberto M. Davalli, Orazio Carandente, Antonio E. Pontiroli, Gerry Melino, Piero Marchetti, Renato Lauro, Giorgio Sesti, Franco Folli
Diabetes Jun 2001, 50 (6) 1290-1301; DOI: 10.2337/diabetes.50.6.1290

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Add to Selected Citations
Share

High Glucose Causes Apoptosis in Cultured Human Pancreatic Islets of Langerhans
Massimo Federici, Marta Hribal, Lucia Perego, Marco Ranalli, Zaira Caradonna, Carla Perego, Luciana Usellini, Rita Nano, Paolo Bonini, Federico Bertuzzi, Lionel N.J.L. Marlier, Alberto M. Davalli, Orazio Carandente, Antonio E. Pontiroli, Gerry Melino, Piero Marchetti, Renato Lauro, Giorgio Sesti, Franco Folli
Diabetes Jun 2001, 50 (6) 1290-1301; DOI: 10.2337/diabetes.50.6.1290
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • RESEARCH DESIGN AND METHODS
    • RESULTS
    • DISCUSSION
    • Acknowledgments
    • Footnotes
    • REFERENCES
  • Figures & Tables
  • Info & Metrics
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Glucagon Resistance and Decreased Susceptibility to Diabetes in a Model of Chronic Hyperglucagonemia
  • Acyl-Ghrelin Influences Pancreatic β-Cell Function by Interference with KATP Channels
  • Pancreatic β-Cell–Specific Deletion of VPS41 Causes Diabetes Due to Defects in Insulin Secretion
Show more Islet Studies

Similar Articles

Navigate

  • Current Issue
  • Online Ahead of Print
  • Scientific Sessions Abstracts
  • Collections
  • Archives
  • Submit
  • Subscribe
  • Email Alerts
  • RSS Feeds

More Information

  • About the Journal
  • Instructions for Authors
  • Journal Policies
  • Reprints and Permissions
  • Advertising
  • Privacy Policy: ADA Journals
  • Copyright Notice/Public Access Policy
  • Contact Us

Other ADA Resources

  • Diabetes Care
  • Clinical Diabetes
  • Diabetes Spectrum
  • Scientific Sessions Abstracts
  • Standards of Medical Care in Diabetes
  • BMJ Open - Diabetes Research & Care
  • Professional Books
  • Diabetes Forecast

 

  • DiabetesJournals.org
  • Diabetes Core Update
  • ADA's DiabetesPro
  • ADA Member Directory
  • Diabetes.org

© 2021 by the American Diabetes Association. Diabetes Print ISSN: 0012-1797, Online ISSN: 1939-327X.